litlas
ログインアカウント作成

Ramesh K. Ramanathan

1999–2024 年に発表

73
論文数
26,367
被引用数
68
h 指数
72
i10 指数

被引用数

Ramesh K. Ramanathan の年別被引用数2000 年: 被引用 3 件2001 年: 被引用 11 件2002 年: 被引用 25 件2003 年: 被引用 41 件2004 年: 被引用 69 件2005 年: 被引用 104 件2006 年: 被引用 116 件2007 年: 被引用 154 件2008 年: 被引用 148 件2009 年: 被引用 166 件2010 年: 被引用 118 件2011 年: 被引用 132 件2012 年: 被引用 154 件2013 年: 被引用 172 件2014 年: 被引用 191 件2015 年: 被引用 250 件2016 年: 被引用 239 件2017 年: 被引用 253 件2018 年: 被引用 284 件2019 年: 被引用 988 件2020 年: 被引用 1,141 件2021 年: 被引用 1,011 件2022 年: 被引用 758 件2023 年: 被引用 499 件2024 年: 被引用 729 件2025 年: 被引用 321 件2026 年: 被引用 12 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,192 件、この内訳の 28.9%中国: 引用元論文 1,212 件、この内訳の 11%イタリア: 引用元論文 622 件、この内訳の 5.6%イギリス: 引用元論文 606 件、この内訳の 5.5%ドイツ: 引用元論文 580 件、この内訳の 5.2%日本: 引用元論文 516 件、この内訳の 4.7%フランス: 引用元論文 457 件、この内訳の 4.1%スペイン: 引用元論文 352 件、この内訳の 3.2%オランダ: 引用元論文 315 件、この内訳の 2.8%カナダ: 引用元論文 304 件、この内訳の 2.8%オーストラリア: 引用元論文 275 件、この内訳の 2.5%韓国: 引用元論文 258 件、この内訳の 2.3%
0%28.9%その他 21.4%

機関

分野

  • Medicine68.1%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Immunology and Microbiology4.3%
  • Materials Science3.6%
  • Engineering1.6%
  • Neuroscience0.7%
  • その他2.2%

トピック

  • Pancreatic and Hepatic Oncology Research10.7%
  • Colorectal Cancer Treatments and Studies3.6%
  • Cholangiocarcinoma and Gallbladder Cancer Studies3.5%
  • Cancer Genomics and Diagnostics2.8%
  • Cancer Immunotherapy and Biomarkers2.6%
  • Cancer Cells and Metastasis2.5%
  • その他74.3%

共著者

全論文

検索で開く
  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    著者: Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante, Malcolm J. Moore, Thomas E. Seay, Sergei Tjulandin, Wen Wee, Mansoor N. Saleh, Marion Harris, Michele Reni, Scot Dowden, Daniel A. Laheru, Nathan Bahary, Ramesh K. Ramanathan, Josep Tabernero, Manuel Hidalgo, David Goldstein, Eric Van Cutsem, Xinyu Wei, José Iglesias, Markus F. Renschler - New England Journal of Medicine 2013 被引用: 6,661

  2. Hepatocytes direct the formation of a pro-metastatic niche in the liver

    著者: Jae W. Lee, Meredith L. Stone, Paige M. Porrett, Stacy K. Thomas, Chad A. Komar, Joey H. Li, Devora Delman, Kathleen Graham, Whitney L. Gladney, Xia Hua, Taylor A. Black, Austin L. Chien, Krishna S. Majmundar, Jeffrey C. Thompson, Stephanie S. Yee, Mark H. O’Hara, Charu Aggarwal, Dong Xin, Abraham Shaked, Mingming Gao, Dexi Liu, Mitesh J. Borad, Ramesh K. Ramanathan, Erica L. Carpenter, Ailing Ji, Maria C. de Beer, Frederick C. de Beer, Nancy R. Webb, Gregory L. Beatty - Nature 2019 被引用: 423

  3. Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

    著者: William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang, John H. Healey, Bartosz Chmielowski, Arthur P. Staddon, Allen Lee Cohn, Geoffrey I. Shapiro, Vicki L. Keedy, Arun S. Singh, Igor Puzanov, Eunice L. Kwak, Andrew J. Wagner, Daniel D. Von Hoff, Glen J. Weiss, Ramesh K. Ramanathan, Jiazhong Zhang, Gaston Habets, Ying Zhang, Elizabeth A. Burton, Gary C. Visor, Laura Sanftner, Paul Severson, Hoa Nguyen, Marie J. Kim, Adhirai Marimuthu, Garson Tsang, Rafe Shellooe, C. M. Gee, Brian L. West, Peter Hirth, K. B. Nolop, Matt van de Rijn, Henry H. Hsu, Charles Peterfy, Paul Lin, Sandra Tong-Starksen, Gideon Bollag - New England Journal of Medicine 2015 被引用: 582

  4. Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

    著者: Milind Javle, Maeve A. Lowery, Rachna T. Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J. Borad, Ramesh K. Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla, Anthony B. El-Khoueiry, Robin Kate Kelley, Ivan Borbath, Su Pin Choo, Do‐Youn Oh, Philip A. Philip, Li‐Tzong Chen, Thanyanan Reungwetwattana, Eric Van Cutsem, Kun‐Huei Yeh, Kristen K. Ciombor, Richard S. Finn, Anuradha Patel, Suman Sen, Dale Porter, Randi Isaacs, Andrew X. Zhu, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab - Journal of Clinical Oncology 2017 被引用: 715

  5. Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

    著者: Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Sunil R. Hingorani, Jill Lacy, Jeremy Kortmansky, Jaykumar Thumar, E. Gabriela Chiorean, Anthony F. Shields, Deepti Behl, Paul Mehan, Rakesh Gaur, Tara Elisabeth Seery, Katherine A. Guthrie, Howard S. Höchster - Journal of Clinical Oncology 2019 被引用: 323

  6. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers

    著者: Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed O. Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios Bekaii‐Saab, Mitesh J. Borad - JAMA Oncology 2019 被引用: 473

  7. Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma

    著者: Ana De Jesus‐Acosta, Elizabeth A. Sugar, Peter J. O’Dwyer, Ramesh K. Ramanathan, Daniel D. Von Hoff, Zeshaan A. Rasheed, Lei Zheng, Asma Begum, Robert A. Anders, Anirban Maitra, Florencia McAllister, N.V. Rajeshkumar, Shinichi Yabuuchi, Roeland F. de Wilde, Bhavina Batukbhai, İsmet Şahin, Daniel A. Laheru - British Journal of Cancer 2019 被引用: 170

  8. Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

    著者: Daniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Daniel A. Laheru, Lon Smith, Tina E. Wood, Ronald L. Korn, Neil Desai, Vuong Trieu, J. L. Mesías Iglesias, Hui Zhang, Patrick Soon‐Shiong, Tao Shi, N.V. Rajeshkumar, Anirban Maitra, Manuel Hidalgo - Journal of Clinical Oncology 2011 被引用: 1,045

  9. Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers

    著者: Johann S. de Bono, Ramesh K. Ramanathan, Lida A. Mina, Rashmi Chugh, John A. Glaspy, Saeed Rafii, Stan B. Kaye, Jasgit C. Sachdev, John V. Heymach, David C. Smith, Joshua W. Henshaw, Ashleigh Herriott, Miranda Patterson, Nicola J. Curtin, Lauren A. Byers, Zev A. Wainberg - Cancer Discovery 2017 被引用: 383

  10. Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors

    著者: Daniel D. Von Hoff, Monica Mita, Ramesh K. Ramanathan, Glen J. Weiss, Alain C. Mita, Patricia LoRusso, Howard A. Burris, Lowell L. Hart, Susan C. Low, Donald M. Parsons, Stephen E. Zale, Jason M. Summa, Hagop Youssoufian, Jasgit C. Sachdev - Clinical Cancer Research 2016 被引用: 272

  11. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

    著者: Patrick J. Loehrer, Yang Feng, Higinia R. Cárdenes, Lynne I. Wagner, Joanna M. Brell, David Cella, Patrick J. Flynn, Ramesh K. Ramanathan, Christopher H. Crane, Steven R. Alberts, Al B. Benson - Journal of Clinical Oncology 2011 被引用: 832

  12. First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors

    著者: John H. Strickler, Colin D. Weekes, John Nemunaitis, Ramesh K. Ramanathan, Rebecca S. Heist, Daniel Morgensztern, Eric Angevin, Todd M. Bauer, Huibin Yue, Monica Motwani, Apurvasena Parikh, Edward B. Reilly, Daniel Afar, Louie Naumovski, Karen Kelly - Journal of Clinical Oncology 2018 被引用: 139

  13. Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

    著者: J. Philip Kuebler, H. Samuel Wieand, Michael J. O’Connell, Roy E. Smith, Linda H. Colangelo, Greg Yothers, Nicholas J. Petrelli, Michael Findlay, Thomas E. Seay, James N. Atkins, John L. Zapas, J. Wendall Goodwin, Louis Fehrenbacher, Ramesh K. Ramanathan, Barbara A. Conley, Patrick J. Flynn, Gamini S. Soori, Lauren K. Colman, Edward A. Levine, Keith S. Lanier, Norman Wolmark - Journal of Clinical Oncology 2007 被引用: 1,053

  14. First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

    著者: Amita Patnaik, Leonard J. Appleman, Anthony W. Tolcher, Kyriakos P. Papadopoulos, Muralidhar Beeram, Drew Rasco, Glen J. Weiss, Jasgit C. Sachdev, Manpreet Chadha, Maddie Fulk, Samuel Ejadi, James M. Mountz, Michael T. Lotze, Frederico G. S. Toledo, Edward Chu, Michael Jeffers, Carol E. Peña, Chenjing Xia, Stefanie Reif, Isabelle Genvresse, Ramesh K. Ramanathan - Annals of Oncology 2016 被引用: 236

  15. Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

    著者: Stergios J. Moschos, Ryan J. Sullivan, Wen-Jen Hwu, Ramesh K. Ramanathan, Alex A. Adjei, Peter C.C. Fong, Ronnie Shapira‐Frommer, Hussein Tawbi, Joseph Rubino, Thomas S. Rush, Da Zhang, Nathan R. Miselis, Ahmed A. Samatar, Patrick Chun, Eric H. Rubin, James E. Schiller, Brian J. Long, Priya Dayananth, Donna Carr, Paul T. Kirschmeier, W. Robert Bishop, Yongqi Deng, Alan Cooper, Gerald W. Shipps, Blanca Homet Moreno, Lídia Robert, Antoni Ribas, Keith T. Flaherty - JCI Insight 2018 被引用: 147

  16. Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours

    著者: Devalingam Mahalingam, Manish R. Patel, Jasgit C. Sachdev, Lowell L. Hart, Niels Halama, Ramesh K. Ramanathan, John Sarantopoulos, Dirk Völkel, Ashraf Youssef, Floris A. de Jong, Apostolia M. Tsimberidou - British Journal of Clinical Pharmacology 2020 被引用: 79

  17. Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort

    著者: Howard A. Burris, Suzanne J. Bakewell, Johanna C. Bendell, Jeffrey R. Infante, Suzanne F. Jones, David R. Spigel, Glen J. Weiss, Ramesh K. Ramanathan, Angela Ogden, Daniel D. Von Hoff - ESMO Open 2016 被引用: 152

  18. First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

    著者: Glen J. Weiss, Joseph Chao, Jeffrey D. Neidhart, Ramesh K. Ramanathan, Dawn Bassett, James A. Neidhart, Chung Hang Jonathan Choi, Warren Chow, Vincent Chung, Stephen J. Forman, Edward G. Garmey, Jungyeon Hwang, D. Lynn Kalinoski, Marianna Koczywas, Jeff Longmate, Roger J. Melton, Robert J. Morgan, J C Oliver, Joanna Peterkin, John L. Ryan, Thomas Schluep, Timothy W. Synold, Przemyslaw Twardowski, Mark E. Davis, Yun Yen - Investigational New Drugs 2013 被引用: 220

  19. A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

    著者: Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, B. Findlay, Henry C. Pitot, Steven R. Alberts - Journal of Clinical Oncology 2003 被引用: 2,268

  20. Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

    著者: Ramesh K. Ramanathan, Ronald L. Korn, Natarajan Raghunand, Jasgit C. Sachdev, Ronald G. Newbold, Gayle Jameson, Gerald J. Fetterly, Joshua Prey, Stephan G. Klinz, Jaeyeon Kim, Jason E. Cain, Bart S. Hendriks, Daryl C. Drummond, Eliel Bayever, Jonathan B. Fitzgerald - Clinical Cancer Research 2017 被引用: 172

  21. A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination

    著者: Ramesh K. Ramanathan, James L. Abbruzzese, Tomislav Dragovich, Lynn Kirkpatrick, Jose Guillen, Amanda F. Baker, Linda Pestano, Sylvan Green, Daniel D. Von Hoff - Cancer Chemotherapy and Pharmacology 2010 被引用: 119

  22. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    著者: Davendra Sohal, Pamela B. Mangu, Alok A. Khorana, Manish A. Shah, Philip A. Philip, Eileen M. O’Reilly, Hope E. Uronis, Ramesh K. Ramanathan, Christopher H. Crane, Anitra Engebretson, Joseph T. Ruggiero, Mehmet Sitki Copur, Michelle Lau, Susan G. Urba, Daniel A. Laheru - Journal of Clinical Oncology 2016 被引用: 353

  23. Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

    著者: Ramesh K. Ramanathan, Kenneth Lee, John McKolanis, Elizabeth Hitbold, Wolfgang H. Schraut, A. James Moser, Elizabeth Warnick, Theresa L. Whiteside, Jennifer Osborne, Hyoung Kim, Roger Day, Monica Troetschel, Olivera J. Finn - Cancer Immunology Immunotherapy 2004 被引用: 219

  24. Phase I Dose-Escalation Study of Taselisib, an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors

    著者: Dejan Juric, Ian E. Krop, Ramesh K. Ramanathan, Timothy R. Wilson, Joseph A. Ware, Sandra Sanabria Bohórquez, Heidi Savage, Deepak Sampath, Laurent Salphati, Ray Lin, Huan Jin, Hema Parmar, Jerry Y. Hsu, Daniel D. Von Hoff, José Baselga - Cancer Discovery 2017 被引用: 160